Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1987 2
1988 1
1990 1
1991 1
1994 1
1995 1
1996 2
1997 1
1998 1
1999 1
2001 3
2002 1
2003 1
2004 1
2017 2
2018 1
2019 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Championing the use of people-first language in childhood overweight and obesity to address weight bias and stigma: A joint statement from the European-Childhood-Obesity-Group (ECOG), the European-Coalition-for-People-Living-with-Obesity (ECPO), the International-Paediatric-Association (IPA), Obesity-Canada, the European-Association-for-the-Study-of-Obesity Childhood-Obesity-Task-Force (EASO-COTF), Obesity Action Coalition (OAC), The Obesity Society (TOS) and the World-Obesity-Federation (WOF).
Weghuber D, Khandpur N, Boyland E, Mazur A, Frelut ML, Forslund A, Vlachopapadopoulou E, Erhardt É, Vania A, Molnar D, Ring-Dimitriou S, Caroli M, Mooney V, Forhan M, Ramos-Salas X, Pulungan A, Holms JC, O'Malley G, Baker JL, Jastreboff AM, Baur L, Thivel D. Weghuber D, et al. Among authors: holms jc. Pediatr Obes. 2023 Jun;18(6):e13024. doi: 10.1111/ijpo.13024. Epub 2023 Apr 1. Pediatr Obes. 2023. PMID: 37002830 No abstract available.
4-hydroxythiazole inhibitors of 5-lipoxygenase.
Kerdesky FA, Holms JH, Moore JL, Bell RL, Dyer RD, Carter GW, Brooks DW. Kerdesky FA, et al. Among authors: holms jh. J Med Chem. 1991 Jul;34(7):2158-65. doi: 10.1021/jm00111a035. J Med Chem. 1991. PMID: 2066989
Discovery and optimization of novel constrained pyrrolopyridone BET family inhibitors.
Fidanze SD, Liu D, Mantei RA, Hasvold LA, Pratt JK, Sheppard GS, Wang L, Holms JH, Dai Y, Aguirre A, Bogdan A, Dietrich JD, Marjanovic J, Park CH, Hutchins CW, Lin X, Bui MH, Huang X, Wilcox D, Li L, Wang R, Kovar P, Magoc TJ, Rajaraman G, Albert DH, Shen Y, Kati WM, McDaniel KF. Fidanze SD, et al. Among authors: holms jh. Bioorg Med Chem Lett. 2018 Jun 1;28(10):1804-1810. doi: 10.1016/j.bmcl.2018.04.020. Epub 2018 Apr 11. Bioorg Med Chem Lett. 2018. PMID: 29678460
Alpha-keto amides as inhibitors of histone deacetylase.
Wada CK, Frey RR, Ji Z, Curtin ML, Garland RB, Holms JH, Li J, Pease LJ, Guo J, Glaser KB, Marcotte PA, Richardson PL, Murphy SS, Bouska JJ, Tapang P, Magoc TJ, Albert DH, Davidsen SK, Michaelides MR. Wada CK, et al. Among authors: holms jh. Bioorg Med Chem Lett. 2003 Oct 6;13(19):3331-5. doi: 10.1016/s0960-894x(03)00685-1. Bioorg Med Chem Lett. 2003. PMID: 12951120
Fragment-Based, Structure-Enabled Discovery of Novel Pyridones and Pyridone Macrocycles as Potent Bromodomain and Extra-Terminal Domain (BET) Family Bromodomain Inhibitors.
Wang L, Pratt JK, Soltwedel T, Sheppard GS, Fidanze SD, Liu D, Hasvold LA, Mantei RA, Holms JH, McClellan WJ, Wendt MD, Wada C, Frey R, Hansen TM, Hubbard R, Park CH, Li L, Magoc TJ, Albert DH, Lin X, Warder SE, Kovar P, Huang X, Wilcox D, Wang R, Rajaraman G, Petros AM, Hutchins CW, Panchal SC, Sun C, Elmore SW, Shen Y, Kati WM, McDaniel KF. Wang L, et al. Among authors: holms jh. J Med Chem. 2017 May 11;60(9):3828-3850. doi: 10.1021/acs.jmedchem.7b00017. Epub 2017 Apr 21. J Med Chem. 2017. PMID: 28368119
Hydroxamic acid inhibitors of 5-lipoxygenase.
Summers JB, Mazdiyasni H, Holms JH, Ratajczyk JD, Dyer RD, Carter GW. Summers JB, et al. Among authors: holms jh. J Med Chem. 1987 Mar;30(3):574-80. doi: 10.1021/jm00386a022. J Med Chem. 1987. PMID: 3820229
Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.
Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK. Wada CK, et al. Among authors: holms jh. J Med Chem. 2002 Jan 3;45(1):219-32. doi: 10.1021/jm0103920. J Med Chem. 2002. PMID: 11754593
Structure-activity relationships of N-hydroxyurea 5-lipoxygenase inhibitors.
Stewart AO, Bhatia PA, Martin JG, Summers JB, Rodriques KE, Martin MB, Holms JH, Moore JL, Craig RA, Kolasa T, Ratajczyk JD, Mazdiyasni H, Kerdesky FA, DeNinno SL, Maki RG, Bouska JB, Young PR, Lanni C, Bell RL, Carter GW, Brooks CD. Stewart AO, et al. Among authors: holms jh. J Med Chem. 1997 Jun 20;40(13):1955-68. doi: 10.1021/jm9700474. J Med Chem. 1997. PMID: 9207936
24 results